Navigation Links
Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
Date:5/16/2008

WEIFANG, Shandong, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today reported financial results for the three months ended March 31, 2008.

Third Quarter of Fiscal 2008 Highlights

-- Sales increased 64.8% to $20.7 million

-- Gross profit rose 37.2% to $4.5 million

-- Gross profit margin was 21.7%

-- Operating income increased 30.4% to $2.9 million

-- Net income increased 5.2% to $ 1.9 million

-- Weighted avg. diluted shares outstanding were 19.8 million vs. 10.1

million

-- Fully diluted EPS was $0.10 versus $0.18

Third Quarter of Fiscal 2008 Results

For the third quarter of fiscal 2008, sales increased 64.8% to $20.7 million from $12.6 million for the third quarter of fiscal 2007.

Cornstarch sales were $7.1 million in this quarter, up 212.5% from $2.3 million in the same period of 2007, sales of glucose products were $7.9 million in this quarter, down 4.3% from $8.3 million in the same period of 2007 and sales of other products were $5.6 million, up 177.5% from $2.0 million in the same period of 2007.

The increased sales of cornstarch resulted in a higher proportion of total cornstarch sales compared to the same reporting period last year. Along with an improving utilization rate of the new cornstarch manufacturing plant, the Company manufactured and sold more cornstarch with lower gross profit margins to generate necessary working capital and funds for construction of its new glucose complex. The significant growth of its other products business was mainly attributable to more sales of higher margin sodium gluconate and cornstarch byproducts associated with the greater operational size of the cornstarch business.

"The sales kept growing during this quarter
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
5. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
6. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
7. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
8. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
9. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... French . ... regenerative medicine. A team led by Ludwik Leibler from ... and Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle ... that the principle of adhesion by aqueous solutions of ... organs and tissues. This easy-to-use gluing method has been ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... School of Medicine (BUSM) have discovered that the ... experimental model. The findings, reported in the ... may lead to more effective treatments for alcoholism. ... the leading causes of illness and death in ... by limiting the productivity of workers and necessitating ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... CME LL C ... Educational Initiatives. In her new role, DeMatteo will guide ... needs through activities founded on proven learning adult principles, ... to CME LLC ...
... in innovative electronic patient reported outcomes (ePRO) solutions and data collection ... and web technologies. assisTek,s ongoing development of Smart Phone and eDiary ... requirements. , ... Scottsdale, AZ (PRWEB) May 12, 2009 ...
... red in honor of world,s largest AIDS fundraising eventLighting ... - 12:15 P.M. Press Opportunities immediately following ... Health Crisis (GMHC) and AIDS Walk New York (AWNY) ... will soon honor the 24th annual AIDS Walk New ...
... Clemson University and Barrett Caldwell of Purdue University have proposed ... monitoring signals in human behavior. The system could result in ... of future phases of an outbreak of an illness such ... to identify a pandemic event before it is under way ...
... Exclusive List of 99 Companies Worldwide CLEVELAND, ... named one of 2009,s World,s Most Ethical Companies by ... two hospitals to make the list of 99 companies.According ... "going beyond legal minimums, introducing innovative ideas to benefit ...
... could be key in improving Alzheimer,s research , , TUESDAY, ... biomarkers in cerebrospinal fluid may help predict the rate ... and this information could be used to improve the ... study, published in the May issue of the journal ...
Cached Medicine News:Health News:Ann Marie DeMatteo Joins CME LLC as Vice President of Educational Initiatives, Drives Innovative Programming Approaches 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 3Health News:Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York 2Health News:Hilary Duff to Light Empire State Building Commemorating 24th Annual AIDS Walk New York 3Health News:Researchers study the human factor in spread of pandemic illness 2Health News:Researchers study the human factor in spread of pandemic illness 3Health News:Cleveland Clinic Named One of World's Most Ethical Companies 2Health News:Cleveland Clinic Named One of World's Most Ethical Companies 3Health News:Biomarkers May Help Measure Rate of Decline in Dementia 2
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... BIRMINGHAM, Ala., June 8, 2011 SANYO North ... its Cell Processing Work Station (CPWS), an integrated, stand-alone ... stem cell and cell therapies for research use, has ... (UAB) as the nation,s first installation of the CPWS, ...
... 2011 According to a report published today by ... has begun to adapt to stricter governmental brand name ... it files for every new drug. These newer standards ... European Medicines Agency (EMA) are part of an effort ...
Cached Medicine Technology:SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 2SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 3Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands 2Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: